Skip to main content

Table 2 Effect estimates of the path analysis of the conceptual model

From: A structural equation model to assess the pathways of body adiposity and inflammation status on dysmetabolic biomarkers via red cell distribution width and mean corpuscular volume: a cross-sectional study in overweight and obese subjects

 

Estimate (β)

Standardized

Estimate (β)a

P (|Z| > z)

95% CI

Direct effect

 BMI → CRP

0.050

0.342

0.008

0.013; 0.087

 BMI → ROS

0.415

0.242

0.047

0.006; 0.825

 BMI → Slope

− 0.012

− 0.153

0.192

− 0.031; 0.006

 BMI → Lag-time

− 0.108

− 0.020

0.873

−1.432; 1.216

 BMI → RDW

−0.132

− 0.229

0.022

− 0.244; − 0.019

 BMI → MCV

0.078

0.070

0.574

−0.194; 0.350

 WC → CRP

−0.002

−0.044

0.682

−0.012; 0.008

 WC → ROS

−0.078

− 0.136

0.283

−0.220; 0.064

 WC → Slope

0.000

0.003

0.975

−0.005; 0.006

 WC → Lag-time

−0.292

− 0.160

0.143

− 0.684; 0.099

 WC → RDW

0.122

0.640

< 0.001

0.089; 0.155

 WC → MCV

−0.061

− 0.165

0.148

− 0.143; 0.022

 CRP → RDW

0.302

0.077

0.085

−0.042; 0.646

 CRP → MCV

−1.446

−0.190

< 0.001

−2.170; − 0.721

 ROS → Slope

0.012

0.263

0.006

0.004; 0.021

 ROS → Lag-time

−1.276

−0.399

< 0.001

−1.867; − 0.685

 ROS → RDW

− 0.017

− 0.052

0.548

−0.074; 0.039

 ROS → MCV

−0.003

− 0.005

0.943

− 0.097; 0.091

 Slope→RDW

0.090

0.013

0.868

−0.971; 1.150

 Slope→MCV

1.264

0.091

0.256

−0.917; 3.444

 Lag-time→RDW

−0.001

−0.009

0.920

−0.019; 0.017

 Lag-time→MCV

0.017

0.086

0.292

−0.015; 0.050

 RDW → HOMA

0.081

0.168

0.016

0.015; 0.146

 RDW → SBP

−0.206

−0.037

0.656

−1.115; 0.702

 RDW → DBP

0.080

0.033

0.660

−0.277; 0.438

 RDW → TGL

−0.007

−0.021

0.762

−0.049; 0.036

 RDW → CHL

−0.009

−0.016

0.831

−0.089; 0.072

 RDW → LDL

0.035

0.071

0.331

−0.036; 0.106

 RDW → HDL

−0.037

−0.192

0.007

−0.065; − 0.010

 RDW → CHL/HDL

0.071

0.117

0.096

−0.012; 0.154

 RDW → BGL

0.044

0.096

0.070

−0.004; 0.091

 RDW → Insulin

0.320

0.153

0.030

0.030; 0.609

 MCV → HOMA

−0.028

−0.112

0.149

−0.066; 0.010

 MCV → SBP

−0.081

−0.028

0.748

−0.576; 0.414

 MCV → DBP

−0.071

−0.057

0.419

−0.244; 0.101

 MCV → TGL

−0.013

−0.081

0.270

−0.036; 0.010

 MCV → CHL

0.037

0.132

0.103

−0.008; 0.082

 MCV → LDL

0.028

0.109

0.122

−0.007; 0.062

 MCV → HDL

0.014

0.136

0.048

0.000; 0.027

 MCV → CHL/HDL

−0.004

−0.014

0.834

−0.044; 0.035

 MCV → BGL

0.007

0.029

0.514

−0.014; 0.027

 MCV → Insulin

−0.160

−0.148

0.050

−0.320; 0.000

  1. In bold:P < 0.05; in italic: 0.05 ≤ P < 0.10
  2. Goodness of fit indexes: chi-square = 168.107 (P < 0.001), baseline chi-square = 1906.191 (P < 0.001), SRMR = 0.091, RMSEA =0.102 (90%CI = 0.084; 0.121), CFI = 0.940, TLI = 0.847
  3. → = effect, BMI = Body Mass Index, WC = Waist Circumference, CRP = C-Reactive Protein, ROS = Reactive Oxygen Species, RDW = Red Cell Distribution Width, MCV = Mean Corpuscular Volume, HOMA = Homeostasis Model Assessment, SBP = Systolic Blood Pressure, DBP = Diastolic Blood Pressure, TGL = Triglycerides, CHL = total cholesterol, LDL = low-density lipoprotein cholesterol, HDL = high-density lipoprotein cholesterol, BGL = Blood Glucose Level
  4. aSince the variables are measured on various scales, standardized estimates (β*) rather than raw effects (β) are shown using the standard deviations as measurement units for the variables. Therefore, these are standardized partial regression coefficients are effects of explanatory variable on response variable, controlling for the other variables of the model